Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almeida, I. C.
Right arrow Articles by Gazzinelli, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almeida, I. C.
Right arrow Articles by Gazzinelli, R. T.
(Journal of Leukocyte Biology. 2001;70:467-477.)
© 2001 by Society for Leukocyte Biology

Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses

Igor C. Almeida* and Ricardo T. Gazzinelli{dagger}

* Department of Parasitology, University of São Paulo, São Paulo, SP, Brazil; and
{dagger} Department of Biochemistry and Immunology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

Correspondence: Dr. Igor C. Almeida, Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1374, São Paulo, SP 05508-900, Brazil. E-mail: ialmeida{at}icb.usp.br


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
A strong activation of macrophages is observed during acute infection with Trypanosoma cruzi. Little is known, however, about the parasite molecules that are responsible for this early activation of innate immunity. Recent studies have shown the stimulatory activity of protozoan-derived glycosylphosphatidylinositol (GPI) anchors on cultured macrophages. In this review, we provide a detailed analysis of the correlation between structure and proinflammatory activity by T. cruzi-derived GPI anchors. We also cover the studies that have identified the Toll-like receptor 2 as a functional GPI receptor and have partially characterized signaling pathways triggered by T. cruzi-derived GPI anchors, which lead to the synthesis of proinflammatory cytokines in macrophages. Finally, we discuss the implications of these findings in resistance and pathogenesis during the infection with T. cruzi.

Key Words: protozoan parasites • macrophages • innate immunity • cytokine • Toll-like receptors


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
Trypanosoma cruzi (T. cruzi) has four distinct developmental stages, epimastigote, metacyclic trypomastigote, amastigote, and blood trypomastigote. The epimastigotes replicate extracellularly in the middle gut of the haematophagous triatomine bug. Once they reach the rectum, they differentiate into metacyclic trypomastigotes that accumulate in the distal intestine portion and are eliminated in the feces, which then contaminate the wound caused by bug-biting the definitive host. To continue the life cycle, the metacyclic trypomastigotes infect host cells and inside them differentiate into the amastigote forms that are responsible for parasite replication. When the host cells become packed with parasites, the amastigotes transform into trypomastigotes, which are released into the extracellular milieu after host-cell membrane disruption. The blood trypomastigote, an extracellular stage of T. cruzi, can infect any nucleated cell they encounter, to continue parasite replication and spreading of infection throughout the host tissues. Blood trypomastigotes of the mammalian host may in turn also infect the blood-sucking insect vector, following transformation into epimastigotes and therefore perpetuation of the T. cruzi life cycle [1 ].

The transmission of T. cruzi by natural vectors, the hematophagous triatomine bugs, occurs in a large area from Southern regions in the United States to Argentina and Chile. Chagas’ disease or American trypanosomiasis, caused by infection with T. cruzi, is a long-lived infection that affects approximately 18 million individuals in Latin America [1 ]. The infection with this trypanosomatid protozoan begins with a short acute phase characterized by high parasitemia and various clinical symptoms including myocarditis. With development of host immunity against T. cruzi, most parasites are cleared from the bloodstream and tissues, the clinical symptoms subside, and an asymptomatic chronic phase is maintained with a scarce number of parasites, which persist for life in most Chagasic patients. However, symptomatic forms may emerge in some chronic Chagasic patients, usually affecting the heart and/or digestive organs [2 ]. Despite the controversy on the mechanism of immunopathogenesis in chronic Chagasic patients [3 ], recent studies indicate that during chronic infection with T. cruzi, parasites are physically associated with the sites of inflammation on the heart [4 , 5 ] and esophagus [6 ]. During infection with T. cruzi, the activation of the immune system is likely to be involved in at least two aspects of Chagas’ disease pathophysiology, which are the control of parasite replication and spread in the host tissues and the inflammatory reaction in infected host tissues. The latter is regarded as a major cause of tissue damage leading to organ dysfunction during acute and chronic phases of the disease.

In fact, early studies demonstrated that host resistance/susceptibility to infection is, at least in part, determined at the very early stages of infection, before the development of adaptive immunity [7 8 9 10 ]. It is believed that the cell functions involved on innate immunity, which are triggered by T. cruzi parasites, may have important consequences on different aspects of T. cruzi infection, such as load of tissue parasitism, tissue tropism, and the pathogenesis of Chagas’ disease. At the onset of infection, T. cruzi activates cells from macrophage lineage to produce high levels of chemokines and proinflammatory cytokines [11 ]. Most notably, the cells exposed to protozoan products will produce interleukin (IL)-12, which is responsible for initiation of interferon-{gamma} (IFN-{gamma}) synthesis by natural killer (NK) cells and which favors the differentiation of Th0 lymphocytes into the Th1 phenotype [11 12 13 ]. Thus far, IFN-{gamma} has been shown to be the crucial cytokine mediating resistance during acute infection with this protozoan. It is noteworthy that different studies show that Trypanosoma products may also serve as a second signal to stimulate the synthesis of reactive nitrogen intermediates (RNI), such as nitric oxide (NO), by IFN-{gamma}-primed macrophages, a phenomenon that is essential for host resistance during early stages of infection with this parasite [8 ].

Little is known about the parasite molecules that trigger functions of the innate immune system during the early stages of protozoan infection. In the last few years, the identification and structural characterization of parasite molecules that initiate the synthesis of proinflammatory cytokines and RNI by macrophages has been the focus of many studies [14 15 16 17 18 19 20 21 22 23 24 25 26 ]. Glycosylphosphatidylinositol (GPI)-anchored molecules are the predominant antigens present on the plasma membrane of parasitic protozoa such as T. cruzi (Fig. 1 ). Experimental evidence strongly suggests that GPI anchors derived from Plasmodium falciparum, Trypanosoma brucei, and T. cruzi play an important role on the activation of the innate immune system during protozoan infection. Among the biological properties of these protozoan-derived glycolipoconjugates are their ability to elicit the synthesis of proinflammatory cytokines and chemokines, generation of RNI, as well as the expression of adhesion molecules by host macrophages and endothelial cells.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 1. Schematic representation of the two major GPI-anchored molecules of the plasma membrane of T. cruzi. Mucin, the mucin-like glycoprotein of the parasite; GIPL, glycoinositolphospholipid. Depending on the developmental stage, the number of these molecules varies from 106 to 107 per cell, and they coat a significant extension (60–80%) of the parasite plasma membrane. The GPI moiety, responsible for relevant cellular and humoral immunological responses, as observed with mucin and GIPL molecules, is shown. Light blue, white, red, and dark blue indicate carbon, hydrogen, oxygen, and nitrogen atoms, respectively. For simplicity, hydrogen atoms are only shown in the lipid moiety of the GPI structure.

 
To better understand the early stimulation of the innate immune system by parasitic protozoa, we have focused on the identification and chemical characterization of T. cruzi products that trigger the proinflammatory and effector functions of macrophages [20 , 21 , 23 , 26 27 28 29 ]. These studies indicate that GPI anchors (tGPIs), highly purified from GPI-anchored, mucin-like glycoproteins (tGPI-mucins) of the mammalian cell-derived T. cruzi trypomastigotes, play an essential role in triggering various macrophage functions. In this review, we intend to cover the molecular studies that have defined the structure of these components from the T. cruzi surface membrane and have led to the partial characterization of some of the signaling pathways responsible for triggering various functions exhibited by macrophages during infection with this protozoan parasite.


    GPI ANCHORS: CORRELATION BETWEEN STRUCTURE AND ACTIVITY ON CELLS FROM MACROPHAGE LINEAGE
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
The majority of free or protein-associated GPIs from eukaryotic cells have in common a hydrophilic core structure with a conserved motif defined by the sequence Man{alpha}1-2Man{alpha}1-6Man{alpha}1-4GlcN{alpha}1-6myo-inositol-1-PO4-. A great variety of closely related structures arise from this conserved motif by the addition of carbohydrate residues (e.g., {alpha}Manp, {alpha}Galp, ßGalp, ßGalf, GlcNAc, and sialic acid) and phosphorylated substituents [i.e., ethanolaminephosphate (EtNP), 2-aminoethylphosphonate (AEP), and Glc{alpha}-1-PO4-]. Such hydrophilic moiety of the GPI anchor is covalently attached, through the myo-inositol-linked phosphate residue to a hydrophobic moiety composed of a glycerolipid or a ceramide. In addition, the myo-inositol ring can be further modified by acylation with palmitic acid (C16:0) or, more rarely, myristic acid (C14:0). In free and protein-associated GPIs, an extensive diversity of structures is also generated at the hydrophobic moiety by qualitative and quantitative changes on the lipid component(s). Many other structural and evolutionary aspects of GPI structures have been reviewed extensively elsewhere [30 31 32 ].

In previous studies conducted in our laboratories, in collaboration with other groups, we have demonstrated that tGPI-mucins and highly purified tGPI elicit a potent proinflammatory response in lipopolysaccharide (LPS)-resistant C3H/HeJ and LPS-sensitive C3H/HeN murine macrophages [20 , 23 ]. The intact tGPI anchor is a remarkably potent activator of murine macrophages, inducing proinflammatory cytokines and NO synthesis in the 0.1–10 nM range. At this level, the tGPI is an inflammatory agent as potent as the bacterial LPS and Mycoplasma lipopeptide. It is interesting that mucin-derived GPIs and free GPIs, the glycoinositolphospholipids (GIPLs) isolated from the insect-derived (epimastigote and metacyclic) T. cruzi developmental stages, are rather poor activators of macrophages when compared with the trypomastigote-derived molecules (tGPI). When used in the 0.1–5.0 µM range, most of the GIPLs and GPI-mucins derived from epimastigotes are able to induce tumor necrosis factor {alpha} (TNF-{alpha}), IL-12, and NO at levels comparable to those observed for P. falciparum and T. brucei GPIs [14 , 17 , 22 , 24 , 25 ]. Considering the extremely short time that the insect-derived stages from T. cruzi persist in the vertebrate host, probably the high concentrations of 0.1–5.0 µM GPI-anchored mucins and/or GIPLs will never be achieved in the case of American trypanosomiasis. Thus, most of our work has been carried out using GPI-anchored mucins derived from the mammalian cell-derived trypomastigote stage of T. cruzi. Nonetheless, structural analytical studies of mucin-derived GPIs and GIPLs, from distinct developmental stages and strains of T. cruzi, have been helpful to establish a correlation between structure and proinflammatory activity in protozoan-derived GPI anchors.

Analysis of tGPI from T. cruzi trypomastigote mucins by electrospray ionization mass spectrometry (ESI-MS) and gas chromatography-mass spectrometry (GC-MS) revealed the presence of four to eight hexoses (Man4 and Gal0–4, in an average ratio of 4:2.5) in the GPI glycan core, as well as EtNP and AEP as phosphorylated substituents [23 ]. The anomeric structure and linkage positions of the Man and Gal residues have not been determined, but it has been assumed that at least the Man residues are arranged in the glycan core as in the conserved motif Man{alpha}1-2Man{alpha}1-2Man{alpha}1-6Man{alpha}1-4GlcN{alpha}1-6 myo-inositol-1-PO4-, commonly shared by all T. cruzi GPI anchors thus far characterized [33 34 35 36 37 38 39 ]. The most striking finding was that the tGPI phosphatidylinositol (PI) moiety is composed of sn-1-O-(C16:0)alkyl-2-O-acylglycerol, containing mainly unsaturated (C18:1 and C18:2) fatty acids at the sn-2 position [20 , 23 ]. Thus far, no other parasite-derived GPI anchor had been shown to contain unsaturated fatty acids [30 , 31 ]. Chemical removal, by alkaline hydrolysis, of the unsaturated C18:1- or C18:2-fatty acid from the sn-2 position of tGPI abrogates most, but not all, of its inflammatory activity. Furthermore, periodate oxidation, which breaks the linkage between carbon atoms containing vicinal hydroxyl groups located at the GPI glycan, and nitrous deamination, which selectively releases the PI moiety from the GPI, leads to the complete inactivation of tGPI. The alkylacylglycerol-phosphoinositol moiety alone, up to 25 nM, was not able to induce cytokines (TNF-{alpha} and IL-12) or NO [20 , 21 , 23 ].

Structural analysis of the GPI anchor isolated from mucin-like glycoproteins of T. cruzi, noninfective insect-derived epimastigotes (eGPI) revealed a conserved glycan sequence (Man{alpha}1-2Man{alpha}1-2Man{alpha}1-6Man{alpha}1-4GlcN{alpha}) and a PI composed exclusively of 1-O-(C16:0)alkyl-2-O-(C16:0 or C18:0)acylglycerol-3-phosphate-1-myo-inositol [23 , 37 , 38 ]. The GPI anchor of mucin-like glycoproteins from the infective, insect-derived metacyclic trypomastigote stage (mGPI) contains the same conserved Man4-GlcN glycan sequence, but the myo-inositol-phosphate-lipid moiety contains predominantly (70%) inositol-phosphoceramides (IPCs) composed of a (d18:0)-sphinganine long-chain base and mainly lignoceric acid (C24:0; 48%) or palmitic acid (C16:0; 15%), and to a lesser extent (30%), 1-O-(C16:0)alkyl-2-O-(C16:0 or C18:0) acylglycerol, also found in eGPIs [38 ]. Aside from the abundantly expressed GPI-mucins [31 , 40 , 41 ], the GIPLs, formerly known as lipopeptidophosphoglycan (LPPG) [42 ], are found on the plasma membrane of all T. cruzi stages and strains thus far investigated [31 , 33 , 34 , 39 , 42 43 44 45 ]. However, they are only abundantly expressed on the insect vector-derived epimastigote and metacyclic stages [33 , 34 , 39 , 42 43 44 45 ]. The GIPLs are also present on other protozoan parasites but not in higher eukaryotic cells [30 , 31 ]. As with any other GPI-anchor, the GIPLs share the conserved hydrophilic motif of Man{alpha}1-4GlcN{alpha}1-6-myo-inositol-1-PO4-. However, various modifications are found in the lipid moiety and carbohydrate branches linked to this conserved core, depending on the parasite species and strain origin. In T. cruzi, for instance, the GIPL lipid moiety contains mainly ceramide ([d18:0]-sphinganine or [d18:1]-sphingosine linked to lignoceric acid or palmitic acid) or sn-1-O-(C16:0)alkyl-2-O-(C16:0 or C18:0)acylglycerol [23 , 39 , 43 ].

eGPI and mGPI-mucins and GIPLs were found to be at least 100- to 1000-fold less active than the tGPI-mucins in the induction of proinflammatory cytokines and NO by murine macrophages [20 , 21 , 23 ]. The primary structure of GPIs from the major T. cruzi mucins and GIPLs are shown in Figure 2A . Comparing the structures of eGPI, mGPI, and tGPI, we notice that the latter has a longer glycan core, due to the extra Gal residues, and a more fluid lipid moiety, because of the presence of an unsaturated fatty acid at the sn-2 position. Most probably, this unique combination makes the tGPI more soluble in aqueous media/phases and with a final tridimensional conformation, which allows it to be more adequately presented to a putative macrophage receptor.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 2.

Primary structure of major protozoan GPI-anchored molecules and their concentration range for cytokine- and NO-inducing activity in murine macrophages. (A) GPI-anchored molecules from T. cruzi. eGIPL and eGPI, the epimastigote-derived glycoinositolphospholipid and the mucin-GPI anchor, respectively; mGPI, the metacyclic-derived mucin-GPI anchor; tGPI, the mucin-GPI anchor from mammalian cell-derived trypomastigote. (B) MSP-GPI, the GPI anchor of P. falciparum merozoite surface protein (MSP); Lm-LPG, the Leishmania major-derived lipophosphoglycan (LPG); VSG-GPI, the GPI anchor derived from T. brucei variant surface glycoprotein (VSG). The fourth Man ({alpha}1,2-linked) residue distal from GlcN, indicated in the MSP-GPI (shaded circle), is also present in all T. cruzi-derived GPI anchors shown in A. m-Ins, myo-inositol; GlcN, glucosamine; Man, mannose; Galf, galactofuranose; AEP, 2-aminoethylphosphonate; EtNP, ethanolaminephosphate; Cer, ceramide; AAG, alkylacylglycerol; MAG, mono- or lyso-alkylglycerol. Otherwise indicated, all monosaccharides are in the D-pyranosyl configuration, except the extra Gal residues of tGPI, whose definitive configuration has not yet been assigned. R, carbohydrate substituent(s). The amide linkage between the C-terminus of the glycopolypeptide and the GPI moiety is shown as a dotted line. The hydrophobic moiety of each GPI is depicted inside a shaded rectangle. The major acyl and/or alkyl species in each GPI structure is/are underlined.

 
Parallel studies have identified GPI anchors as major proinflammatory agents in P. falciparum and T. brucei. Schofield and collaborators [14 , 16 17 18 19 ] and Gerold et al. [15 ] showed that the GPI anchors isolated from the erythrocytic stage of the P. falciparum-derived merozoite surface proteins (MSP-1 and MSP-2), at 0.1–10 µM concentration range, could induce TNF-{alpha} and IL-1 production by murine macrophages. Removal of the fatty acids linked to the glycerol portion by specific phospholipases completely abolished the cytokine induction, indicating that the lipid moiety could play an essential role in the macrophage-activation process [14 ]. Similar data were obtained with GPI anchors purified from the variant surface glycoprotein (VSG) of T. brucei trypomastigotes [16 ].

Further, comparing the cytokine- and NO-inducing activity of GPIs isolated from P. falciparum MSP and T. brucei VSG, Tachado et al. [19 ] demonstrated that the GPI glycosyl-inositolphosphate sequence could activate protein tyrosine kinase (PTK). Conversely, the diacylglycerol moieties of the P. falciparum and T. brucei GPIs were able to activate protein kinase C-{varepsilon} (PKC-{varepsilon}). Together, the GPI glycosyl-inositolphosphate and the diacylglycerol moieties from these protozoan GPIs had a synergistic effect in triggering the synthesis of TNF-{alpha}. Magez et al. [22 ] have also demonstrated that highly purified, GPI-anchored VSG from T. brucei is able to induce TNF-{alpha} and IL-1{alpha} production by LPS-low-reponsive (C3H/HeJ) and LPS-responsive (C3H/HeN) murine macrophages. The TNF-{alpha}-inducing activity is mapped to the Man{alpha}1-2Man{alpha}1-6-({alpha}Gal2–4)Man{alpha}1-4GlcN{alpha}1-6myo-inositol-1-HPO4 moiety of the VSG-GPI, and the IL-1{alpha}-inducing activity is found to be associated with the sn-1,2-O-dimiristoylglycerol moiety of the GPI anchor. It is interesting that the {alpha}Gal residues were found to be critical for optimal induction of TNF-{alpha}.

Additional efforts have been made to characterize the GPI anchors from the MSP family members of P. falciparum intraerythrocytic stages [15 , 46 ]. It has been proposed that the MSP contains two GPI species: a major one, Pfg1{alpha}, with a sequence of EtNP-(Man{alpha}1-2)-Man{alpha}1-2Man{alpha}1-6Man{alpha}1-4GlcN1-6(myristoyl)-myo-inositol-1-PO4--sn-1,2-(C16:0/C16:0)diacylglycerol, and a minor one, Pfg1ß, lacking the fourth Man residue distal from GlcN [15 , 46 ]. In a more recent study, Naik et al. [24 ] were able to elegantly perform, for the first time in the malaria research field, a direct structural analysis by chemical and enzymatic methods as well as mass spectrometry of free and MSP-derived GPIs from P. falciparum erythrocytic stages. The glycan core structures of MSP-1, MSP-2, and MSP-4 were found to be identical to those previously described [15 , 46 47 48 ]. In contrast, the major lipid constituents of the PI moiety differ from those observed by metabolic labeling [46 ]. For instance, at the C-2 of the myo-inositol ring, myristic acid (C14:0) only accounted for 10% of the total acylation, whereas the major (90%) substituent was palmitic acid (C16:0). The PI diacylglycerol moiety contained at the sn-1 position mainly C18:0 (80%), C16:0 (12%), and small amounts of C14:0 (4%), C20:0 (2%), and C22:0 (2%). Conversely, at the sn-2 position, C18:1 (two isomers, oleic and cis-vaccenic acids, 88%) and C18:2 (12%) were characterized as the main substituents [24 ]. These fatty acids have been previously found at the sn-2 position of the alkylacylglycerol portion of the potent inflammatory GPI anchors from T. cruzi tGPI-mucins [20 , 23 ]. Free GPIs or GIPLs are also present in P. falciparum and are similar to MSP-derived GPIs, because oleic acid ({triangleup}9-cis, ~85%), linoleic acid (~9%), and cis-vaccenic ({triangleup}11-cis, ~6%) are the main fatty acids at the sn-2 position, whereas stearic acid and palmitic acid are the main substituents at the sn-1 position [24 ]. It was also shown that highly purified free or protein-linked P. falciparum GPIs, in the 0.03–0.5 µM range, could elicit TNF-{alpha} by murine macrophages, confirming previous data obtained by Schofield and collaborators [14 , 16 ]. The structure of the major P. falciparum-derived MSP-GPI is shown in Figure 2B .

In a more recent study, Vijaykumar et al. [25 ] have shown that the TNF-{alpha}-inducing activity of P. falciparum-free GPIs is dependent on the recognition of the fourth distal Man residue (see Fig. 2B ), because the removal of this residue by jack bean {alpha}-mannosidase completely abolished the cytokine secretion. Preincubation of macrophages with methyl-{alpha}-mannopyranoside, mannobiose (Man{alpha}1-2Man) and Man4-GlcN-myo-Ins-PO4- led to full inhibition of the native GPI activity. The authors suggested that the mechanism of macrophage activation by P. falciparum GPI could involve its recognition by a putative macrophage mannose receptor, rather than endocytosis or membrane insertion of the GPI. It is worth noting that most GPI anchors from T. cruzi contain the fourth {alpha}Man residue distal to GlcN [23 , 30 , 31 , 33 34 35 36 37 38 39 , 41 ] (Fig. 2A and 2B) . Whether the presence of this {alpha}Man residue is critical for the cytokine-/NO-inducing activity of these GPIs is still an open question.

The TNF-{alpha}-inducing activity of P. falciparum GPIs is also dependent on the presence of an intact GPI structure. Chemical treatments with fluoridic acid, which breaks the linkage between the phosphate and the myo-inositol residue, and with nitrous acid, which breaks the bond between the {alpha}GlcN and myo-inositol residues, completely abolished the GPI TNF-{alpha}-inducing activity. Removal of both fatty acids at sn-1 and sn-2 positions and the extra fatty acid at the C-2 of myo-inositol by alkaline hydrolysis with methanolic ammonia also completely abrogated TNF-{alpha} induction. Surprisingly, the fatty acid (oleic or linoleic) at sn-2 does not seem to be essential for eliciting TNF-{alpha}, because the sn-2 lyso-GPI species in the 250–1000 nM range has the same activity as the native, fully-acylated Plasmodium GPI [25 ]. This result is in apparent contradiction with previous observations with T. cruzi-derived tGPIs, in which the unsaturated fatty acid at the sn-2 position was critical for the potent induction of TNF-{alpha}, IL-12, and NO [20 , 23 ]. It is important to mention that the sn-2 lyso-GPI species from P. falciparum still contains two fatty acid chains, one at the C-2 of the myo-inositol ring and the other at the sn-1 position of the glycerol moiety (Fig. 2B) . The latter might serve as a replacement for the absent fatty acid at the sn-2 position in the lyso-GPI species.

It is interesting that branched iM4-GIPLs [Man{alpha}1-2Man{alpha}1-6(Man{alpha}1-3)Man{alpha}1-4GlcN{alpha}1-6-PI] from infective promastigote forms of Leishmania mexicana and lipophosphoglycan (LPG) from the infective promastigote or amastigote form of L. donovani and L. major [30 , 31 , 49 , 50 ] at concentrations up to ~5 µM did not elicit TNF-{alpha} or NO production by murine macrophages [18 , 21 ]. We carefully looked at the primary structure of Leishmania LPG and noticed that it contains a glycan motif distinct from other protozoan GPIs (Fig. 2) . None of Leishmania GIPLs or LPG species thus far described contain the fourth Man{alpha}1-2-linked residue distal from GlcN [30 , 31 ]. Maybe the lack of this residue, as in the case of Plasmodium Man3-GlcN-PI [25 ], makes the Leishmania LPG and GIPLs completely inactive as a macrophage activator. In addition, the LPG and GIPL species from Leishmania spp. have longer (C18:0–C26:0) alkyl chains at sn-1 position [30 , 31 , 51 ], which may turn them less soluble and, perhaps, with a conformation not so adequate for effectively interacting with the putative macrophage receptor.


    CHARACTERIZATION OF THE SIGNALING PATHWAY IN MACROPHAGES TRIGGERED BY T. CRUZI-DERIVED GPI ANCHORS
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
Despite the growing evidence implicating GPI structures from parasitic protozoa in the induction of monokine synthesis as well as in effector functions by macrophages, not much is known about the receptor(s) and signaling pathways that are triggered by these GPI anchors. Therefore, we have decided to characterize some of the signaling pathways triggered by the tGPI in inflammatory macrophages, which are responsible for initiating the synthesis of proinflammatory cytokines and NO [26 , 28 ]. Our results show that tGPI or tGPI-mucins trigger phosphorylation of mitogen-activated protein kinases (MAPK; i.e., ERK-1/ERK-2, SKK-1/MKK-4, and SAPK-2/p38). The use of specific inhibitors of ERK-1/ERK-2 (PD 98059) and SAPK-2/p38 (SB 203580) phosphorylation blocked the activation of the cAMP-responsive element-binding protein (CREB). The effect of PD 98059 alone is only marginal, whereas in combination with SB 203580, it reaches, respectively, 80 and 50% of inhibition for TNF{alpha} and IL-12 synthesis by macrophages exposed to tGPI-mucin or tGPI. Furthermore, tGPI and tGPI-mucin were able to induce phosphorylation of I{kappa}B and the use of SN50 peptide, an inhibitor of nuclear factor (NF)-{kappa}B translocation, resulted in 70% of TNF-{alpha} synthesis, only marginally affecting the production of IL-12 by macrophages exposed to tGPI-mucin or tGPI [28 ].

In addition, we have shown that cAMP-mimetic or -enhancing agents are efficient inhibitors of TNF-{alpha} and IL-12 synthesis while increasing IL-10 production in macrophages exposed to tGPI-mucin. The inhibitory effect cAMP-mimetic or -enhancing agents on TNF-{alpha} and IL-12 synthesis was partially reversed by the PKA inhibitor H-89. Exogenous IL-10 was also shown to effectively inhibit the synthesis of proinflammatory cytokines by macrophages exposed to tGPI-mucin or tGPI. It is interesting that in macrophages pre-treated with cAMP-mimetic or -enhancing agents, endogenous IL-10 is apparently involved in the regulation of IL-12 but not of TNF-{alpha} synthesis stimulated by T. cruzi glycolipids [26 ].


    IDENTIFICATION OF MACROPHAGE COUNTERPART RECEPTORS FOR T. CRUZI-DERIVED GPI ANCHORS
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
Together, our findings indicate that the recognition system for the stimulatory tGPI-mucins appears to share much in common with the recognition system of LPS. Thus, LPS and tGPI-mucin (or tGPI) trigger the same pattern of phosphorylation of different members of the MAPK family and I{kappa}B [28 ]. In addition, similar IC50 values of inhibitors specific for different MAPKs, NF-{kappa}B, and cAMP-mimetic or -enhancing agents are required to inhibit the synthesis of different cytokines (i.e., TNF-{alpha} and IL-12) in macrophages exposed to LPS, tGPI-mucin, or tGPI [26 , 28 ]. Furthermore, our studies demonstrate that pretreatment with LPS or tGPI-mucins effectively induces a state of cross-tolerance between these microbial stimuli [28 ].

Considering the recent studies describing the involvement of the Toll-like-receptors (TLR) on macrophage responsiveness to bacterial glycolipids/lipopeptides [52 53 54 55 56 57 58 59 ], we have investigated the role of TLR2 and TLR4 on induction of cytokine and NO synthesis by macrophages exposed to GPI-mucins and GIPLs derived from different T. cruzi developmental stages. Activation of TLRs leads to translocation of the transcription factor NF-{kappa}B. Therefore, we used Chinese hamster ovary (CHO) cells transfected with TLR2 and/or TLR4 as well as the reporter CD25 (IL-2 receptor) gene, under a promoter that is highly responsive to NF-{kappa}B [60 ], to test the activity of the T. cruzi glycolipids [29 ]. Our results show that tGPIs or tGPI-mucins, in the 1–10 nM range, trigger maximal surface expression of CD25 in CHO cells transfected with TLR2 but not with TLR4. Consistent with our findings in macrophages, GPI-mucins and GIPLs derived from the epimastigote stage of T. cruzi in the 100 nM–1 µM range, were able to trigger significant CD25 expression in the surface of CHO cells transfected with TLR2. More importantly, by using cells from TLR2 or TLR4 knock-out mice, our results indicate the essential involvement of TLR2, but not TLR4, in the induction of IL-12, TNF-{alpha}, and NO by murine-inflammatory macrophages activated by tGPI or tGPI-mucins [29 ].

Thus, the parasite GPI-anchored molecules share with other microbial lipoconjugates, such as bacterial LPS/lipid A (from Gram-negative bacteria); triacylated lipoproteins (LP) and lipoteichoic acid (LTA; from Gram-positive bacteria); peptidoglycan (PG); Mycoplasma-diacylated macrophage-activating lipoprotein/lipopeptide (MALP-2); and Mycobacterium lipoarabinomannan (LAM), the ability to efficiently trigger various functions in cells from macrophage lineage [54 ]. However, we are intrigued by the fact that the specificity of TLR2 allows the recognition of molecules with such distinct, primary structure. Thus, in the next section, we will carry out a brief molecular comparative analysis between bacterial lipoconjugates and protozoal GPI anchors aiming to visualize some of their common structural features and individual characteristics, which could explain, at least in part, why these molecules use a similar class of receptors.


    COMPARATIVE STRUCTURAL ANALYSIS OF PROTOZOAN AND BACTERIAL GLYCOLIPIDS/LIPOPEPTIDES THAT ACTIVATE CELLS FROM INNATE IMMUNE SYSTEM
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
In recent years, there have been many studies attempting to elucidate the molecular mechanisms involved in recognition of microbial products by cells of the innate immunity system, particularly macrophages [55 ]. These microbial products recognized by the innate immune system have been defined as "pathogen-associated molecular patterns" (PAMPs) [53 ], because in many cases they are conserved in certain groups of pathogenic microbes serving as a molecular identity or signature. The PAMPs are recognized by counterpart receptors, called pattern-recognition receptors (PRRs) [53 ], which are responsible for microbial opsonization, complement activation, and phagocytosis (e.g., collectins and the macrophage mannose-receptor) [61 , 62 ], or induction of proinflammatory signaling pathways such as the TLRs. The molecular and functional aspects of TLRs have been reviewed extensively elsewhere [53 54 55 56 57 58 59 ].

In the last few years, an increasing number of studies have clearly described the involvement of TLRs in the recognition of lipid-containing PAMPs, such as LPS/lipid A, LTA, LP, MALP, and LAM. The lipid-containing PAMPs and protozoal GPI anchors share two basic motifs or features: one hydrophobic moiety, consisting of at least one lipid substituent; and a hydrophylic cap, comprising water-soluble or polar components, such as carbohydrates, amino acids, cyclic alcohols (e.g., myo-inositol), and phosphorylated substituent groups (e.g., PO4-, EtNP, and AEP). The overall structures of the major lipid-containing PAMPs, most of them known to be recognized by TLRs, are shown in Figure 3 [23 , 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ].



View larger version (35K):
[in this window]
[in a new window]
 
Figure 3. General structure of the major lipid-containing PAMPs and the Toll-like receptors triggered by them. GPI, glycosylphosphatidylinositol from T. cruzi. CHO, carbohydrate substituent(s); EtNP, ethanolaminephosphate; AEP, aminoethylphosphonate. AraLAM, arabinofuranosyl-terminated lipoarabinomannan from the avirulent Mycobacterium smegmatis. R1, R2 and R3, the branching chains containing mainly ßAraf and {alpha}Man residues; also, a terminal phosphoinositol residue is found at R2. C19:0, 10-methyl-C18:0 or tuberculostearic acid. LTA, lipoteichoic acid from Gram-positive bacteria. OH, hydroxyl group; Ala, alanine; GroP, glycerol-phosphate residue; GlcNAc, N-acetylglucosamine. MALP-2, macrophage-activating lipopeptide 2 from Mycoplasma fermentans. Lipid A, lipid-A portion derived from E. coli LPS. The hydrophobic moiety of each PAMP is depicted inside a shaded retangle. (*) TLR2 is activated in vitro, whereas TLR4 is involved in the response in vivo in knock-out mice [54 , 70 ]. (#) More recently, it has been shown that LPS molecules purified from Porphyromonas gingivalis [81 ] and Leptospira interrogans[82 ] activate TLR2 instead of TLR4. LPS-derived, lipid-A moiety from these organisms lack the myristic and 3-hydroxy-myristic acids at 3' position on the nonreducing GlcN and have rather longer fatty acids (C15:0–C17:0), substituting both GlcN residues. A more detailed description of the lipid-containing PAMP structures shown here can be found elsewhere [23 , 30 , 31 , 63 64 65 66 , 69 70 71 72 73 74 75 76 77 78 79 80 , 83 , 89 ].

 
It is worth noting that most lipid-containing PAMPs (i.e., LAM, LTA, and MALP) that activate TLR2 share in common with GPI anchors the presence of a glycerol moiety, to which one or two fatty acids or alkyl chains (as in the case of T. cruzi GPIs) can be covalently attached. Additionally, an extra acylation can be found in the myo-inositol ring of GPI and LAM [24 , 66 ]. Chemical or enzymatic treatments, which partially or completely remove the fatty acids from LAM [63 , 64 ], MALP [71 , 72 ], and protozoal GPIs [14 , 20 , 23 , 25 ] cause a significant decrease or loss of the glycolipid bioactivity. Consistenly, a recombinant protein lacking the diacylglycerol moiety but encoding the N-terminal MALP-2 sequence is not able to induce proinflammatory cytokines in murine macrophages [76 ]. In contrast, introduction of an extra fatty acid on the N-terminal cysteine-free amino group of MALP causes a significant reduction on its activity [74 ]. Remarkably, change in configuration at the C-2 of the diacylglycerolipid moiety of the 2-kDa MALP (MALP-2), from R- to S-stereoisomer, resulted in a 100-fold reduction in the cytokine-inducing activity [75 ]. In the case of LPS and lipid A, the location, number, and length of fatty acids attached to the two GlcN residues are also critical for the proinflammatory activity of the molecule [77 78 79 80 , 83 84 85 ]. In Escherichia coli lipid A, the number of fatty acid chains can vary from four to eight, with the most active form containing six fatty acid chains, five myristic acid (C14:0), and one lauric acid (C12:0) [80 , 83 , 84 ].

It is also interesting that in some PAMPs that activate TLR2, the lipid moiety is connected to the glycan portion through a phosphoinositol moiety, as in GPI and LAM, but not in LTA and MALP. The myo-inositol ring can be further modified by adding mainly C16:0-fatty acid at C-2, as in P. falciparum GPI [24 ] (Fig. 2B) ; or an {alpha}Man residue and a fatty acid (of unknown nature) at C-2 and C-3, respectively, as in M. bovis bacillus Calmette-Guerin (BCG) cellular LAM [66 ]. In this type of LAM the myo-inositol-linked {alpha}Man residue can be even further substituted by an acyl chain not yet characterized. The presence of two to four fatty acids in the cellular LAM makes this compound a poor inducer of proinflammatory cytokines by human dendritic cells (DCs), comparable in activity to the complete, deacylated LAM. In contrast, the parietal LAM, apparently comprising only one single fatty acid at C-1, namely 12-O-(methoxypropanoyl)-12-O-hydroxy-stearic acid, can potently induce IL-8 and TNF-{alpha} by human DCs [86 87 88 89 ].

On the hydrophylic moiety, most lipid-containing PAMPs, except MALP, share a glycan core, whose primary function might be to improve the solubility of the whole molecule. It is interesting that MALPs isolated from different Mycoplasma species and containing distinct N-terminal hydrophilic sequences show similar cytokine-inducing activity [73 , 74 ]. This result is strong evidence that the hydrophylic core of a PAMP primarily serves just to enable an adequate solubility to the lipopeptide during presentation to the TLR-mediated macrophage-activating system. The second function of the hydrophylic moiety of a PAMP, regardless of whether it is a glycan or peptide, might be to provide specific, structural motifs, which could be recognized by putative co-receptor(s) on the plasma membrane of cells of the innate immune system. This happens, for instance, in the case of two distinct forms of LAM, the mannose-capped LAM (ManLAM) and the arabinofuranosyl-terminated LAM (AraLAM), which differ from each other in the number and linkage positions of carbohydrate and other substituents linked to the lipomannan (LM) core containing the PI moiety. As a result, AraLAM isolated from avirulent mycobacteria is a much better activator of murine macrophages and human monocytes than ManLAM, purified from virulent Mycobacterium [88 , 89 ]. The precise importance of the hydrophilic core of most PAMPs in this interaction, however, is still unknown and soon should be the focus of exciting structural and functional studies.


    IMPLICATIONS OF THE RESISTANCE TO AND PATHOGENESIS OF T. CRUZI INFECTION
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
The studies describing the proinflammatory activity of tGPI-mucins or tGPI have all been performed in vitro. An attempt has been made to generate T. cruzi parasites devoid of GPI anchors. T. cruzi parasites were stably transfected with phospholipase C (PLC) and had a reduced number of GPI anchors [90 ]. Although mice infected with these parasites showed less inflammation at the site of infection, the biological significance of these findings was questioned because the transgenic parasites had an intrinsic defect of replication and the tissue parasitism was also diminished as compared with wild type parasites [91 ]. Thus, the implications of the role of T. cruzi-derived GPI anchors and related structures in resistance to and pathogenesis of T. cruzi infection are mostly speculative.

T. cruzi can infect and replicate inside any kind of nucleated cell in the vertebrate host. If not controlled by the immune system, the T. cruzi parasites become highly virulent and leads to generalized infection, which is always fatal in few days. The fast elimination of the definitive host is an obvious limitation for parasite persistence in its life cycle. In contrast, the long-living, chronically infected host will increase the chances of T. cruzi transmission to the insect vector, thus maintaining the parasite life cycle in nature. As mentioned above, the early resistance to T. cruzi is highly dependent on the endogenous synthesis of IL-12, TNF-{alpha} and IFN-{gamma}, which will culminate on the release of RNI by macrophages and control of parasite replication during the early stages of infection [8 9 10 ]. Therefore, our in vitro studies suggest a possible role for the tGPI-mucins (or tGPI) in the activation of cells from macrophage lineage [20 , 21 , 23 ], triggering an early resistance mediated by the innate immunity during the acute phase of infection with T. cruzi, before the establishment of acquired immunity. The ability of T. cruzi parasites to evade various effector functions displayed by cells from the innate immune system has also been described. We believe therefore that the balance between early activation of innate immunity by tGPI-mucins and parasite evasion is an essential step in the T. cruzi life cycle, which determines the survival of the definitive host by limiting parasite replication; however, this is not sufficient to eliminate the parasite from host tissues.

Another possible role for tGPI-mucins (or tGPI) in the pathophysiology of Chagas’ disease is the potentiation of the inflammatory reaction at the site of parasitic infection. It has been shown that infection with T. cruzi trypomastigotes (or exposure to tGPI-mucins) triggers macrophages [27 , 92 , 93 ] or cardiomyocytes [94 ] to release chemothatic factors such as the serum amyloid A protein and various chemokines. Therefore, we speculate that tGPI-mucins from the trypomastigote stage of T. cruzi could act as an adjuvant, promoting the inflammatory reaction observed in the infected host tissue, which is regarded as the major cause of tissue damage and organ dysfunction during acute and chronic phases of the disease.


    CONCLUSIONS AND FUTURE DIRECTIONS
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
Taken together, the extensive data discussed above clearly indicate that, in most cases, there is a dual requirement for glycan and lipid components for induction of proinflammatory cytokines and NO synthesis in macrophages exposed to protozoan parasite-derived GPIs. Subtle differences in lipid and carbohydrate composition of a GPI may profoundly affect the potency of its proinflammatory activity. Aside from the fine specificity required for a close interaction between GPI anchor and receptor, we believe that a compromise between hydrophilic and hydrophobic GPI moieties might be critical for its proper solubility, tridimensional conformation, and appropriate presentation to the putative macrophage receptor(s). We hope that future studies using chemically synthesized GPI anchors and GPI fragments may help to further elucidate the structural requirements for macrophage activation by protozoan-derived GPI anchors.

In regard to the counterpart receptors involved on macrophage activation by GPI anchors from T. cruzi, our data clearly show the involvement of TLR2. It has been suggested that different TLRs work in a combined form [54 , 95 ] so that it will be important to investigate the involvement of other TLRs on macrophage activation by GPI anchors from T. cruzi parasites. The involvement of other co-receptors such as the CD14 or the mannose receptor, involved on macrophage activation by bacterial glycolipids [54 , 95 ] or P. falciparum-derived GPI anchors [25 ], remains to be investigated in the context of macrophage activation by T. cruzi-derived GPI anchors. In addition, the investigation of TLR activation by GPI anchors from other protozoan parasites is an important issue. These and other questions should help to further elucidate the molecular interactions involved on macrophage activation by protozoan parasites and provide new insights to avoid excessive inflammatory responses during infection with these parasites.

Finally, the importance of the proinflammatory activity of the T. cruzi-derived GPI anchors in the pathophysiology of Chagas’ disease remains to be clarified. The identification of TLRs as important receptors for macrophage activation by T. cruzi-derived GPI anchors and the generation of various knock-out mice for such receptors should help to evaluate the importance of these dominant protozoan-derived glycolipids in the parasite:vertebrate host interaction. In addition, TLRs appear to be highly conserved, being ancient receptors that confer a certain degree of specificity to the innate immune system from invertebrate and vertebrate hosts [96 ]. Therefore, the interaction of TLRs and GPI anchors from parasitic protozoa may have the important role of determining the fate of parasitism in insects as well. Further understanding of the interaction of GPI anchors and related structures with receptors from the TLR family may also be helpful to develop new prophylactic strategies to fight the debilitating and often fatal diseases caused by distinct protozoan parasites.


    ACKNOWLEDGEMENTS
 
I. C. A. is supported by FAPESP (No. 98/10495-5) and WHO-TDR (ID No. 990942) and is a research fellow from CNPq (No. 300719/99-0). R. T. G. is supported by CNPq (521.117/98), CNPq/PADCT, and WHO/TDR (ID. No. A00477) and is a research fellow from CNPq (No. 522.056/95-4). The authors are most grateful to Profs. Michael A. J. Ferguson and Luiz R. Travassos for their great contributions to the field of parasite molecular research and particularly to the studies on T. cruzi GPIs. The authors also thank Prof. Luiz R. Travassos for critically reviewing the manuscript. We also express our gratitude to all colleagues and students involved in some of the studies discussed here.

Received May 31, 2001; revised July 3, 2001; accepted July 5, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 GPI ANCHORS: CORRELATION BETWEEN...
 CHARACTERIZATION OF THE...
 IDENTIFICATION OF MACROPHAGE...
 COMPARATIVE STRUCTURAL ANALYSIS...
 IMPLICATIONS OF THE RESISTANCE...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 

  1. . World Health Organization (1993) Chagas’ disease Tropical Disease Research. Twelfth Programme of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) ,125 Geneva World Health Organization.
  2. Rassi, A., Luquetti, A. O., Rassi, A., Jr, Rassi, S. G., Rassi, A. G. (1992) Chagas disease—clinical features Wendel, S. Brener, Z. Camargo, M. E. Rassi, A. eds. Chagas Disease (American trypanosomiasis): Its Impact on Transfusion and Clinical Medicine International Society of Blood Transfusion (ISBT) Brazil ’92 São Paulo.
  3. Brener, Z., Gazzinelli, R. T. (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas’ disease Int. Arch. Allergy Immunol. 114,103-110[Medline]
  4. Jones, E. M., Colley, D. G., Tostes, S., Lopes, E. R., Vnencak-Jones, C. L., McCurley, T. L. (1993) Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy Am. J. Trop. Med. Hyg. 48,348-357
  5. Higuchi, M. L., Brito, T., Reis, M. M., Barbosa, A., Bellotti, G., Pereira-Barreto, A. C., Pileggi, F. (1993) Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immuno-histochemical findings Cardiovasc. Pathol. 2,101-106
  6. Vago, A. R., Macedo, A. M., Adad, S. J., Reis, D. D., Correa-Oliveira, R. (1996) PCR detection of Trypanosoma cruzi in oesophageal tissues of patients with chronic digestive Chagas’ disease Lancet 348,891-892[Medline]
  7. Trischmann, T. M. (1986) Trypanosoma cruzi: early parasite proliferation and host resistance in inbred strains of mice Exp. Parasitol. 62,194-201[Medline]
  8. Silva, J. S., Vespa, G. N. R., Cardoso, M. A. G., Aliberti, J. C., Cunha, F. Q (1995) Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi in mice by inducing nitric oxide production in infected IFN-{gamma}-activated macrophages Infect. Immun. 63,4862-4867[Abstract]
  9. Cardillo, F., Voltarelli, J. C., Reed, S. G., Silva, J. S. (1996) Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells Infect. Immun. 64,128-134[Abstract]
  10. Aliberti, J. C. S., Cardoso, M. A. G., Martins, G. A., Gazzinelli, R. T., Vieira, L. Q., Silva, J. S. (1996) IL-12 mediates resistance to Trypanosoma cruzi infection in mice and is produced by normal murine macrophages in response to live trypomastigote Infect. Immun. 64,1961-1967[Abstract]
  11. Biron, C. A., Gazzinelli, R. T. (1995) Effects of IL-12 on immune response to microbial infections: a key mediator in regulating disease outcome Curr. Opin. Immunol. 7,485-497[Medline]
  12. Sharton-Kersten, T., Sher, A. (1997) Role of natural killer cells in innate resistance to protozoan infection Curr. Opin. Immunol. 9,44-51[Medline]
  13. Ropert, C., Gazzinelli, R. T. (2000) Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa Curr. Opin. Microbiol. 3,395-403[Medline]
  14. Schofield, L., Hackett, F. (1993) Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites J. Exp. Med. 177,145-153[Abstract/Free Full Text]
  15. Gerold, P., Dieckmann-Schuppert, A., Schwarz, R. T. (1994) Glycosylphosphatidyl-inositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenic factors. J. Biol. Chem. 269,2597-2606
  16. Tachado, S. D., Schofield, L. (1994) Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction Biochem. Biophys. Res. Commun. 205,984-991[Medline]
  17. Schofield, L., Novakovic, S., Gerold, P., Schwarz, R. T., McConville, M. J., Tachado, S. D. (1996) Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction J. Immunol. 156,1886-1896[Abstract]
  18. Tachado, S. D., Gerold, P., McConville, M. J., Baldwin, T., Quilici, D., Schwarz, R. T., Schofield, L. (1996) Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway J. Immunol. 156,1897-1907[Abstract]
  19. Tachado, S. D., Gerold, P., Schwarz, R. T., Novakovic, S., McConville, M., Schofield, L. (1997) Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties Proc. Natl. Acad. Sci. USA 94,4022-4027[Abstract/Free Full Text]
  20. Camargo, M. M., Almeida, I. C., Pereira, M. E., Ferguson, M. A. J., Travassos, L. R., Gazzinelli, R. T. (1997) Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages J. Immunol. 158,5890-5901[Abstract]
  21. Camargo, M. M., Andrade, A. C., Almeida, I. C., Travassos, L. R., Gazzinelli, R. T. (1997) Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages J. Immunol. 159,6131-6139[Abstract]
  22. Magez, S., Stijlemans, B., Radwanska, M., Pays, E., Ferguson, M. A. J., Debestlier, P. (1998) The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the Trypanosoma variant-specific surface glycoprotein are distinct macrophage activating factors J. Immunol. 160,1949-1956[Abstract/Free Full Text]
  23. Almeida, I. C., Camargo, M. M., Procopio, D. O., Silva, L. S., Mehlert, A., Travassos, L. R., Gazzinelli, R. T., Ferguson, M. A. J. (2000) Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents EMBO J 19,1476-1485[Medline]
  24. Naik, R. S., Branch, O. H., Woods, A. S., Vijaykumar, M., Perkins, D. J., Nahlen, B. L., Lal, A. A., Cotter, R. J., Costello, C. E., Ockenhouse, C. F., Davidson, E. A., Gowda, D. C. (2000) Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis J. Exp. Med. 192,1563-1576[Abstract/Free Full Text]
  25. Vijaykumar, M., Naik, R. S., Gowda, D. C. (2001) Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-alpha secretion by macrophages is mediated without membrane insertion or endocytosis J. Biol. Chem. 276,6909-6912[Abstract/Free Full Text]
  26. Procopio, D. O., Teixeira, M. M., Camargo, M. M., Travassos, L. R., Ferguson, M. A. J., Almeida, I. C., Gazzinelli, R. T. (1999) Differential inhibitory mechanism of cyclic AMP on TNF-{alpha} and IL-12 synthesis by macrophages exposed to microbial stimuli Br. J. Pharmacol. 127,1195-1205[Medline]
  27. Ferreira, L. R. P., Silva, A. M., Michailowsky, V., Reis, L. F. L., Gazzinelli, R. T. (1999) Expression of serum amyloid A3 mRNA by inflammatory macrophages exposed to membrane glycoconjugates from Trypanosoma cruzi J. Leukoc. Biol. 66,593-600[Abstract]
  28. Ropert, C., Almeida, I. C., Closel, M., Travassos, L. R., Ferguson, M. A. J., Cohen, P., Gazzinelli, R. T. (2001) Requirement of MAP kinases and I{kappa}B phosphorylation for induction of proinflammatory cytokines by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial LPS J. Immunol. 166,3423-3431[Abstract/Free Full Text]
  29. Campos, M. A., Almeida, I. C., Takeuchi, O., Akira, S., Valente, E. P., Procopio, D. O., Travassos, L. R., Smith, J. A., Golenbock, D. T., Gazzinelli, R. T. (2001) Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite J. Immunol. 167,416-423[Abstract/Free Full Text]
  30. McConville, M. J., Ferguson, M. A. J. (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes Biochem. J. 294,305-324
  31. Ferguson, M. A. J. (1997) The surface glycoconjugates of trypanosomatid parasites Philos. Trans. R. Soc. Lond. B Biol. Sci. 352,1295-1302[Medline]
  32. Ferguson, M. A. J. (1999) The structure, byosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research J. Cell Sci. 112,2799-2809[Abstract]
  33. Previato, J. O., Gorin, P. A., Mazurek, M., Xavier, M. T., Fournet, B., Wieruszesk, J. M., Mendonça-Previato, L. (1990) Primary structure of the oligosaccharide chain of lipopeptidophosphoglycan of epimastigote forms of Trypanosoma cruzi J. Biol. Chem. 265,2518-2526[Abstract/Free Full Text]
  34. De Lederkremer, R. M., Lima, C., Ramirez, M. I., Ferguson, M. A. J., Homans, S. W., Thomas-Oates, J. (1991) Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi epimastigotes J. Biol. Chem. 266,23670-23675[Abstract/Free Full Text]
  35. Güther, M. L., Cardoso de Almeida, M. L. C., Yoshida, N., Ferguson, M. A. J. (1992) Structural studies on the glycosylphosphatidylinositol membrane anchor of Trypanosoma cruzi 1G7-antigen The structure of the glycan core. J. Biol. Chem. 267,6820-6828
  36. Couto, A. S., de Lederkremer, R. M., Colli, W., Alves, M. J. (1993) The glycosylphosphatidylinositol anchor of the trypomastigote-specific Tc-85 glycoprotein from Trypanosoma cruzi. Metabolic-labeling and structural studies Eur. J. Biochem. 217,597-602[Medline]
  37. Previato, J. O., Jones, C., Xavier, M. T., Wait, R., Travassos, L. R., Parodi, A. J., Mendonça-Previato, L. (1995) Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain J. Biol. Chem. 270,7241-7250[Abstract/Free Full Text]
  38. Serrano, A. A., Schenkman, S., Yoshida, N., Mehlert, A., Richardson, J. M., Ferguson, M. A. J. (1995) The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms J. Biol. Chem. 270,27244-27253[Abstract/Free Full Text]
  39. Carreira, J. C., Jones, C., Wait, R., Previato, J. O., Mendonça-Previato, L. (1996) Structural variation in the glycoinositolphospholipids of different strains of Trypanosoma cruzi Glycoconj. J. 13,955-966[Medline]
  40. Frasch, A. C. (2000) Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi Parasitol. Today 16,282-286[Medline]
  41. Acosta-Serrano, A., Almeida, I. C., Freitas-Junior, L. H., Yoshida, N., Schenkman, S. (2001) The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles Mol. Biochem. Parasitol. 114,143-150[Medline]
  42. De Lederkremer, R. M., Alves, M. J., Fonseca, G. C., Colli, W. (1976) A lipopeptidophosphoglycan from Trypanosoma cruzi (epimastigota). Isolation, purification and carbohydrate composition Biochim. Biophys. Acta 444,85-96[Medline]
  43. De Lederkremer, R. M., Lima, C. E., Ramirez, M. I., Goncalvez, M. F., Colli, W. (1993) Hexadecylpalmitoylglycerol or ceramide is linked to similar glycophosphoinositol anchor-like structures in Trypanosoma cruzi Eur. J. Biochem. 218,929-936[Medline]
  44. Golgher, D. B., Colli, W., Souto-Padron, T., Zingales, B. (1993) Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi Mol. Biochem. Parasitol. 60,249-264[Medline]
  45. Pereira-Chioccola, V. L., Acosta-Serrano, A., Correia de Almeida, I., Ferguson, M. A., Souto-Padron, T., Rodrigues, M. M., Travassos, L. R., Schenkman, S. (2000) Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies J. Cell Sci. 113,1299-1307[Abstract]
  46. Gerold, P., Schofield, L., Blackman, M. J., Holder, A. A., Schwarz, R. T. (1996) Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum Mol. Biochem. Parasitol. 75,131-143[Medline]
  47. Berhe, S., Schofield, L., Schwarz, R. T., Gerold, P. (1999) Conservation of structure among glycosylphosphatidylinositol toxins from different geographic isolates of Plasmodium falciparum Mol. Biochem. Parasitol. 103,273-278[Medline]
  48. Gowda, D. C., Gupta, P., Davidson, E. A. (1997) Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum J. Biol. Chem. 272,6428-6439[Abstract/Free Full Text]
  49. Turco, S. J., Descoteaux, A. (1992) The lipophosphoglycan of Leishmania Annu. Rev. Microbiol. 46,65-94[Medline]
  50. Descoteaux, A., Turco, S. J. (1999) Glycoconjugates in Leishmania infectivity Biochim. Biophys. Acta 1455,341-352[Medline]
  51. Zawadzki, J., Scholz, C., Currie, G., Coombs, G. H., McConville, M. J. (1998) The glycoinositolphospholipids from Leishmania panamensis contain unusual glycan and lipid moieties J. Mol. Biol. 282,287-299[Medline]
  52. Medzhitov, R., Preston-Hurlburt, P., Janeway, C. A. (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388,394-397[Medline]
  53. Janeway, C. A., Jr, Medzhitov, R. (1998) Introduction: the role of innate immunity in the adaptive immune response Semin. Immunol. 10,349-350[Medline]
  54. Aderem, A., Ulevitch, R. J. (2000) Toll-like receptors in the induction of the innate immune response Nature 406,782-787[Medline]
  55. Medzhitov, R., Janeway, C. (2000) Innate immunity N. Engl. J. Med. 343,338-344[Free Full Text]
  56. Imler, J. L., Hoffmann, J. A. (2000) Toll and Toll-like proteins: an ancient family of receptors signaling infection Rev. Immunogenet. 2,294-304[Medline]
  57. Kaisho, T., Akira, S. (2000) Critical roles of Toll-lik